Home » Newsletters » BioWorld Asia

BioWorld Asia

April 19, 2000

View Archived Issues

Mergers, Alliances Help Improve Bottom Lines Of European Sector

Rat Study Shows Brain Stem Cells Could Deliver Therapies

European Parliament Votes For Tighter Restrictions On GMOs

Genset, Sanofi-Synthilabo Enter Pharmacogenomics Collaboration

Atugen Enters Target Validation Deal With Boehringer Ingelheim

Other News To Note

Founder Populations Elucidate Genetics Of Complex Disorders

Australian Center Opens To Make Chirally Pure Compounds

British Biotech Forms Alliance To Gets Access To U.S. Data

Geron Official Says UK Ban On Cloning Hinders Research

L'Orial Adopts Chemunex D-Scan Microbial Analyzer

Medigene Acquires Novel 'In Vitro Heart' Technology

Synt:em Confirms Potential Of Pep:trans Drug Delivery Method

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...